BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21568694)

  • 1. A comparative study of experimental rat models of renal calcium oxalate stone formation.
    Oh SY; Kwon JK; Lee SY; Ha MS; Kwon YW; Moon YT
    J Endourol; 2011 Jun; 25(6):1057-61. PubMed ID: 21568694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
    Liu J; Cao Z; Zhang Z; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
    Li Y; McMartin KE
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Rongshi granule on renal stone formation and osteopontin expression in rat urolithiasis model].
    Huang P; Yang SW; Huang WH; Kong FZ; Lou YJ
    Zhongguo Zhong Yao Za Zhi; 2006 Jul; 31(14):1188-91. PubMed ID: 17048592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.
    Yagisawa T; Ito F; Osaka Y; Amano H; Kobayashi C; Toma H
    J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of female sex hormones on urinary stone formation in rats.
    Iguchi M; Takamura C; Umekawa T; Kurita T; Kohri K
    Kidney Int; 1999 Aug; 56(2):479-85. PubMed ID: 10432386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of urinary proteins in the rat strain difference in sensitivity to ethylene glycol-induced renal toxicity.
    Li Y; McLaren MC; McMartin KE
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F605-15. PubMed ID: 20534866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors.
    Huang HS; Chen J; Chen CF; Ma MC
    Kidney Int; 2006 Aug; 70(4):699-710. PubMed ID: 16807540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection.
    Okada A; Nomura S; Higashibata Y; Hirose M; Gao B; Yoshimura M; Itoh Y; Yasui T; Tozawa K; Kohri K
    Urol Res; 2007 Apr; 35(2):89-99. PubMed ID: 17393196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats.
    Naghii MR; Eskandari E; Mofid M; Jafari M; Asadi MH
    Int Urol Nephrol; 2014 Jun; 46(6):1231-8. PubMed ID: 24554217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model.
    Zhu W; Xu YF; Feng Y; Peng B; Che JP; Liu M; Zheng JH
    Urolithiasis; 2014 Dec; 42(6):519-26. PubMed ID: 25085199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of long-term loading of cholesterol in renal crystal formation.
    Itoh Y; Yoshimura M; Niimi K; Usami M; Hamamoto S; Kobayashi T; Hirose M; Okada A; Yasui T; Tozawa K; Kohri K
    Arch Ital Urol Androl; 2011 Mar; 83(1):23-5. PubMed ID: 21585165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat.
    Zhai W; Zheng J; Yao X; Peng B; Liu M; Huang J; Wang G; Xu Y
    BMC Complement Altern Med; 2013 Sep; 13():228. PubMed ID: 24044655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.
    Itoh Y; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
    J Urol; 2005 Jan; 173(1):271-5. PubMed ID: 15592095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthosiphon grandiflorum has a protective effect in a calcium oxalate stone forming rat model.
    Akanae W; Tsujihata M; Yoshioka I; Nonomura N; Okuyama A
    Urol Res; 2010 Apr; 38(2):89-96. PubMed ID: 20221591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.